Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



PFIZER INC. Hits Price Target Forecast with 10.49% Profit: A Success Story for QuantWave

November 30, 2022

Pfizer Inc. stock has successfully reached the price target forecast set by QuantWave, resulting in a profit of 10.49%. The forecast signal was given on September 6, 2022, with the stock trading at $39.48. The predicted direction was long, and on November 30, 2022, the stock price reached $43.62, achieving the target.

This success in hitting the forecasted price target for Pfizer Inc. showcases the accuracy and reliability of QuantWave's analytics. Market analysis indicates that various factors, such as positive news regarding Pfizer's vaccine developments or overall market sentiment towards the pharmaceutical sector, could have contributed to the stock's movement aligning with the forecast.

QuantWave, as an automated forecasting platform, provides users with predictions for a wide range of stocks, offering opportunities for potential profits similar to the Pfizer Inc. forecast. For those interested in exploring the investment strategy further, QuantSchool is recommended for its comprehensive professional investment framework, guiding users on generating consistent income using the QuantWave forecasting system.

Find out how the PFIZER INC. rate is expected to change

Get Forecast for PFE
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for PFE

PFEJune 6, 2025PFIZER INC. PFE Partners with Acepodia, Innovating Cancer Treatments  ~1 min.

Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....

PFEApril 4, 2025PFIZER INC. Hits Forecast Price Target with 7.0% Profit - QuantWave Analysis  ~1 min.

PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....

PFEApril 3, 2025PFIZER INC. Hits Price Target Forecast with 7.05% Profit  ~1 min.

QuantWave's forecast for PFIZER INC. proved to be successful as the stock reached the predicted target price of 23.84 $ on April 3, 2025, from the initial signal date of May 7, 2024, when the price was at 25....

PFEMarch 27, 2025With 67 ownership Pfizer Inc. NYSE:PFE boasts of strong institutional backing  ~1 min.

Pfizer Inc., a renowned pharmaceutical company, is currently enjoying the support of strong institutional investors with a significant 67% ownership....

PFEMarch 21, 2025Analyst Says Pfizer PFE Stock Will Move Too Fast to Catch  ~1 min.

According to recent analysis by Stocks Prognosis, Pfizer Inc. (NYSE:PFE) is expected to experience significant movement in its stock price in the near future....



Related news

REGNAugust 19, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.57% Profit Margin  ~1 min.

On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....

REGNAugust 13, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 14.62%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast as predicted by QuantWave's automated forecasting platform....

VRTXJune 4, 2024VERTEX PHARMACEUTICALS Stock Hits Forecasted Price Target with 14.32% Profit: QuantWave Analysis  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors....

GSKJune 2, 2025QuantWave Achieves 11.28% Profit Target Forecast for GSK PLC  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a long position for GSK PLC on April 1, 2025, when the stock was trading at $37.44....